<b>Results:</b> While no significant synergistic effects were observed in survival endpoints, differences emerged at the level of early DNA damage effects, with IDH1-mutant glioma cells displaying an enhanced acute response following combined treatment with proton irradiation. The gene discussed is IDH1; the disease is central nervous system cancer.